News & Events
March 21, 2019
C-Path Selects Global Regulatory Affairs Leader as New President and CEO
After a worldwide search, the Critical Path Institute (C-Path) today announced it has appointed Joseph Scheeren, Pharm. D., as its new President and Chief Executive Officer. Scheeren previously served as Senior Advisor Research and Development for Bayer AG and has had a distinguished 36-year career in the pharmaceutical industry having held positions domestically and internationally in drug development and regulatory approval on three continents.
May 1, 2019 - May 3, 2019
2019 Annual International Neonatal Scientific WorkshopDear Colleague, You are cordially invited to participate in the 2019 Annual International Neonatal Consortium Workshop at the Hyatt Regency Bethesda on May 1st – 3rd, 2019. This workshop will build on the progress of INC Work Groups to improve the conduct of trials to evaluate the safety and effectiveness of therapies for neonates. Meetings...
April 24, 2019 - April 25, 2019
Tenth Annual Patient-Reported Outcome Consortium WorkshopWHAT: Tenth Annual Patient-Reported Outcome Consortium Workshop WHEN: April 24-25, 2019 WHERE: Sheraton Silver Spring, Silver Spring, MD The Tenth Annual Patient-Reported Outcome Consortium Workshop will be on Wednesday, April 24 and Thursday, April 25, 2019 at the Sheraton Silver Spring, in Silver Spring MD. A detailed agenda and logistics are currently being developed and...
April 17, 2019 - April 18, 2019
2019 PSTC Japan Safety Biomarker Conference
The Critical Path Institute’s (C-Path) Predictive Safety Testing Consortium (PSTC), with the cooperation and support of the RIKEN research institute, Japan’s National Institute of Health Sciences (NIHS), the Japanese Society of Toxicology (JSOT) and Japan Pharmaceutical Manufacturers Association (JPMA), is delighted to announce the 2019 PSTC Japan Safety Biomarker Conference to be held April 17-18, 2019, in Yokohama, Japan.
April 16, 2019
C-Path, CDISC Develop Therapeutic Area Standard to Foster More Efficient and Meaningful Research for HIVTUCSON, Ariz. and AUSTIN, April 16, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announce the release of a global Therapeutic Area Standard that specifies how to structure commonly collected data and outcome measurements in clinical trials for HIV. The standard, released in the form of User Guide for data...
April 9, 2019
C-Path Receives Qualification from FDA for the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD)TUCSON, Ariz., April 9, 2019 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces U.S. Food and Drug Administration (FDA) qualification of two new clinical outcome assessment tools: the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD). The qualification of the ADSD and the ANSD represents a major...